[1]
|
Cramer, S.F., Aikawa, M., Cebelin, M. and Cebelin, M. (1981) Neurosecretory Granules in Small Cell Invasive Carcinoma of the Urinary Bladder. Cancer, 47, 724-730.
http://dx.doi.org/10.1002/1097-0142(19810215)47:4<724::AID-CNCR2820470417>3.0.CO;2-2
|
[2]
|
Koay, E.J., Teh, B.S., Paulino, A.C. and Butler, E.B. (2011) A Surveillance, Epidemiology, and End Results Analysis of Small Cell Carcinoma of the Bladder: Epidemiology, Prognostic Variables, and Treatment Trends. Cancer, 117, 5325-5333. http://dx.doi.org/10.1002/cncr.26197
|
[3]
|
Koay, E.J., Teh, B.S., Paulino, A.C. and Butler, E.B. (2012) Treatment Trends and Outcomes of Small-Cell Carcinoma of the Bladder. International Journal of Radiation Oncology * Biology * Physics, 83, 64-70.
http://dx.doi.org/10.1016/j.ijrobp.2011.05.039
|
[4]
|
Walenkamp, A.M., Sonke, G.S. and Sleijfer, D.T. (2009) Clinical and Therapeutic Aspects of Extrapulmonary Small Cell Carcinoma. Cancer Treatment Reviews, 35, 228-236. http://dx.doi.org/10.1016/j.ctrv.2008.10.007
|
[5]
|
van Meerbeeck, J.P., Fennell, D.A. and De Ruysscher, D.K. (2011) Small-Cell Lung Cancer. Lancet, 378, 1741-1755.
http://dx.doi.org/10.1016/S0140-6736(11)60165-7
|
[6]
|
Schreiber, D., Rineer, J., Weiss, J., Leaf, A., Karanikolas, N., Rotman, M. and Schwartz, D. (2013) Characterization and Outcomes of Small Cell Carcinoma of the Bladder Using the Surveillance, Epidemiology, and End Results Database. American Journal of Clinical Oncology, 36, 126-131. http://dx.doi.org/10.1097/COC.0b013e3182438c71
|
[7]
|
Macedo, L.T., Ribeiro, J., Curigliano, G., Fumagalli, L., Locatelli, M., Carvalheira, J.B., Quintela, A., Bertelli, S. and De Cobelli, O. (2011) Multidisciplinary Approach in the Treatment of Patients with Small Cell Bladder Carcinoma. European Journal of Surgical Oncology, 37, 558-562. http://dx.doi.org/10.1016/j.ejso.2011.04.005
|
[8]
|
Cheng, L., Pan, C.X., Yang, X.J., Lopez-Beltran, A., MacLennan, G.T., Lin, H., Kuzel, T.M., Papavero, V., Tretiakova, M., Nigro, K., et al. (2004) Small Cell Carcinoma of the Urinary Bladder: A Clinicopathologic Analysis of 64 Patients. Cancer, 101, 957-962. http://dx.doi.org/10.1002/cncr.20456
|
[9]
|
Karpman, E., Goldberg, Z., Saffarian, A., Gandour-Edwards, R., Ellison, L.M. and de Vere White, R.W. (2004) Analysis of Treatment for Small Cell Cancer of the Bladder and Report of Three Cases. Urology, 64, 494-498.
http://dx.doi.org/10.1016/j.urology.2004.04.038
|
[10]
|
Mukesh, M., Cook, N., Hollingdale, A.E., Ainsworth, N.L. and Russell, S.G. (2009) Small Cell Carcinoma of the Urinary Bladder: A 15-Year Retrospective Review of Treatment and Survival in the Anglian Cancer Network. BJU International, 103, 747-752. http://dx.doi.org/10.1111/j.1464-410X.2008.08241.x
|
[11]
|
Bex, A., Nieuwenhuijzen, J.A., Kerst, M., Pos, F., van Boven, H., Meinhardt, W. and Horenblas, S. (2005) Small Cell Carcinoma of Bladder: A Single-Center Prospective Study of 25 Cases Treated in Analogy to Small Cell Lung Cancer. Urology, 65, 295-299. http://dx.doi.org/10.1016/j.urology.2004.09.049
|
[12]
|
Brenner, B., Tang, L.H., Shia, J., Klimstra, D.S. and Kelsen, D.P. (2007) Small Cell Carcinomas of the Gastrointestinal Tract: Clinicopathological Features and Treatment Approach. Seminars in Oncology, 34, 43-50.
http://dx.doi.org/10.1053/j.seminoncol.2006.10.022
|
[13]
|
Meng, M.B., Zaorsky, N.G., Jiang, C., Tian, L.J., Wang, H.H., Liu, C.L., Wang, J., Tao, Z., Sun, Y., Pang, Q.S., et al. (2013) Radiotherapy and Chemotherapy Are Associated with Improved Outcomes over Surgery and Chemotherapy in the Management of Limited-Stage Small Cell Esophageal Carcinoma. Radiotherapy & Oncology, 106, 317-322.
http://dx.doi.org/10.1016/j.radonc.2013.01.008
|
[14]
|
Renner, G. (2007) Small Cell Carcinoma of the Head and Neck: A Review. Seminars in Oncology, 34, 3-14.
http://dx.doi.org/10.1053/j.seminoncol.2006.10.024
|
[15]
|
Hatoum, G.F., Patton, B., Takita, C., Abdel-Wahab, M., La Fave, K., Weed, D. and Reis, I.M. (2009) Small Cell Carcinoma of the Head and Neck: The University of Miami Experience. International Journal of Radiation Oncology * Biology * Physics, 74, 477-481. http://dx.doi.org/10.1016/j.ijrobp.2008.08.014
|
[16]
|
Auperin, A., Arriagada, R., Pignon, J.P., Le Pechoux, C., Gregor, A., Stephens, R.J., Kristjansen, P.E., Johnson, B.E., Ueoka, H., Wagner, H. and Aisner, J. (1999) Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission. Prophylactic Cranial Irradiation Overview Collaborative Group. New England Journal of Medicine, 341, 476-484. http://dx.doi.org/10.1056/NEJM199908123410703
|
[17]
|
Slotman, B., Faivre-Finn, C., Kramer, G., Rankin, E., Snee, M., Hatton, M., Postmus, P., Collette, L., Musat, E. and Senan, S. (2007) Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer. New England Journal of Medicine, 357, 664-672. http://dx.doi.org/10.1056/NEJMoa071780
|
[18]
|
Bex, A., Sonke, G.S., Pos, F.J., Brandsma, D., Kerst, J.M. and Horenblas, S. (2010) Symptomatic Brain Metastases from Small-Cell Carcinoma of the Urinary Bladder: The Netherlands Cancer Institute Experience and Literature Review. Annals of Oncology, 21, 2240-2245. http://dx.doi.org/10.1093/annonc/mdq225
|
[19]
|
Siefker-Radtke, A.O., Kamat, A.M., Grossman, H.B., Williams, D.L., Qiao, W., Thall, P.F., Dinney, C.P. and Millikan, R.E. (2009) Phase II Clinical Trial of Neoadjuvant Alternating Doublet Chemotherapy with Ifosfamide/Doxorubicin and Etoposide. Journal of Clinical Oncology, 27, 2592-2597.
|